Comparison between Brooks Laboratories IPO and PG Electroplast IPO.
Brooks Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while PG Electroplast IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Brooks Laboratories IPO is up to ₹63.00 Cr whereas the issue size of the PG Electroplast IPO is up to ₹120.65 Cr. The final issue price of Brooks Laboratories IPO is ₹100.00 per share and of PG Electroplast IPO is ₹210.00 per share.
| Brooks Laboratories IPO | PG Electroplast IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹90.00 per share | ₹190.00 per share |
| Issue Price (Upper) | ₹100.00 per share | ₹210.00 per share |
| Issue Price (Final) | ₹100.00 per share | ₹210.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | 30 shares |
| Fresh Issue Size | 63,00,000 shares | 57,45,000 shares |
| Fresh Issue Size (Amount) | up to ₹63.00 Cr | up to ₹120.65 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 63,00,000 shares | 57,45,000 shares |
| Issue Size Total (Amount) | up to ₹63.00 Cr | up to ₹120.65 Cr |
Brooks Laboratories IPO opens on Aug 16, 2011, while PG Electroplast IPO opens on Sep 07, 2011. The closing date of Brooks Laboratories IPO and PG Electroplast IPO is Aug 18, 2011, and Sep 12, 2011, respectively.
| Brooks Laboratories IPO | PG Electroplast IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 16, 2011 | Sep 07, 2011 |
| Issue Close | Aug 18, 2011 | Sep 12, 2011 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 05, 2011 | Sep 26, 2011 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Brooks Laboratories IPO P/E ratio is , as compared to PG Electroplast IPO P/E ratio of .
| Brooks Laboratories IPO | PG Electroplast IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.5 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 60.77 | 65 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹161.86 Cr. | ₹344.70 Cr. | ||||
| ROE | ||||||
| ROCE | 27.3 | 31.36 | ||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 47.4 | 41 |
In the Brooks Laboratories IPO Retail Individual Investors (RII) are offered 22,05,000 shares while in PG Electroplast IPO retail investors are offered 22,05,000 shares. Qualified Institutional Buyers (QIB) are offered 31,50,000 shares in Brooks Laboratories IPO and 28,72,500 shares in PG Electroplast IPO.
| Brooks Laboratories IPO | PG Electroplast IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 31,50,000 shares | 28,72,500 shares |
| NII | 9,45,000 shares | 8,61,750 shares |
| RII | 22,05,000 shares | 20,10,750 shares |
| Employee | ||
| Others | ||
| Total | 63,00,000 shares | 57,45,000 shares |
Brooks Laboratories IPO subscribed 1.78x in total, whereas PG Electroplast IPO subscribed 1.34x.
| Brooks Laboratories IPO | PG Electroplast IPO | |
|---|---|---|
| QIB (times) | 0.00x | 0.98x |
| NII (times) | 3.13x | 1.84x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.73x | 1.64x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.78x | 1.34x |
